Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
作者信息
Enserink Martin
出版信息
Science. 2009 Feb 27;323(5918):1162-3. doi: 10.1126/science.323.5918.1162.
Abstract
摘要
相似文献
1
Drug resistance. A 'wimpy' flu strain mysteriously turns scary.耐药性。一种“软弱”的流感毒株神秘地变得可怕起来。
Science. 2009 Feb 27;323(5918):1162-3. doi: 10.1126/science.323.5918.1162.
2
Virology. Helping the resistance.病毒学。助力抗药性。
Science. 2010 Jun 4;328(5983):1243-4. doi: 10.1126/science.1190994.
3
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.探究奥司他韦（达菲）与2009年甲型H1N1流感病毒神经氨酸酶相互作用的见解。
Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.
4
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.预防期间出现对奥司他韦耐药的大流行性H1N1病毒。
N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11.
5
Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.抗病毒药物对2009年甲型H1N1流感病毒的敏感性。
Biochem Biophys Res Commun. 2009 Jul 31;385(3):390-4. doi: 10.1016/j.bbrc.2009.05.066. Epub 2009 May 20.
6
Global transmission of oseltamivir-resistant influenza.耐奥司他韦流感病毒的全球传播。
N Engl J Med. 2009 Mar 5;360(10):953-6. doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2.
7
First isolation of a oseltamivir-resistant influenza A (H1N1) strain in Argentina.在阿根廷首次分离出对奥司他韦耐药的甲型H1N1流感毒株。
Pediatr Infect Dis J. 2010 Apr;29(4):384. doi: 10.1097/INF.0b013e3181cd7244.
8
Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.奥司他韦增强 2009 年 H1N1 病毒的体外感染力。
Biochem Biophys Res Commun. 2009 Dec 25;390(4):1305-8. doi: 10.1016/j.bbrc.2009.10.142. Epub 2009 Oct 29.
9
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.检测与奥司他韦耐药相关的 H275Y 突变在严重大流行流感病毒 A/H1N1 09 感染中的快速出现。
Antiviral Res. 2010 Jul;87(1):16-21. doi: 10.1016/j.antiviral.2010.04.002. Epub 2010 Apr 10.
10
Oseltamivir resistance: what does it mean clinically?奥司他韦耐药性：临床意义何在？
Clin Infect Dis. 2009 Dec 15;49(12):1836-7. doi: 10.1086/648425.
引用本文的文献
1
A New Strategy to Reduce Influenza Escape: Detecting Therapeutic Targets Constituted of Invariance Groups.一种减少流感逃逸的新策略：检测由不变性基团构成的治疗靶点。
Viruses. 2017 Mar 2;9(3):38. doi: 10.3390/v9030038.
2
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.一种非 VH1-69 异源中和性人源单克隆抗体可保护小鼠免受 H1N1 和 H5N1 病毒感染。
PLoS One. 2012;7(4):e34415. doi: 10.1371/journal.pone.0034415. Epub 2012 Apr 4.
3
Co-lethality studied as an asset against viral drug escape: the HIV protease case.作为对抗病毒药物逃逸的资产而研究的共同致死性：HIV 蛋白酶案例。
Biol Direct. 2010 Jun 17;5:40. doi: 10.1186/1745-6150-5-40.
4
Unifying vertical and nonvertical evolution: a stochastic ARG-based framework.统一垂直进化和非垂直进化：基于随机 ARG 的框架。
Syst Biol. 2010 Jan;59(1):27-41. doi: 10.1093/sysbio/syp076. Epub 2009 Nov 9.
5
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets.新型抗严重流感单克隆抗体：雪貂的预防和治疗效果。
PLoS One. 2010 Feb 8;5(2):e9106. doi: 10.1371/journal.pone.0009106.
Zotero 插件